Galapagos N.V. | Ownership
Companies that own Galapagos N.V.
Fidelity Management & Research Co.
2,542,573
4.95%
2,542,573
0.03%
12/06/2017
Capital Research & Management Co. (World Investors)
2,188,989
4.26%
0
0.03%
06/30/2018
Wellington Management Co. LLP
1,333,317
2.6%
-616,593
0.03%
12/30/2016
The Vanguard Group, Inc.
1,112,143
2.17%
21,050
0%
07/31/2018
OppenheimerFunds, Inc.
1,004,216
1.96%
59,205
0.06%
03/31/2018
CAPFI DELEN Asset Management SA
829,126
1.62%
51,926
0.36%
06/30/2018
Federated Global Investment Management Corp.
799,200
1.56%
177,400
0.57%
06/29/2018
Norges Bank Investment Management
707,441
1.38%
-181,748
0.01%
12/31/2017
BlackRock Fund Advisors
410,769
0.8%
220
0%
09/06/2018
Dimensional Fund Advisors LP
374,148
0.73%
24,469
0.01%
04/30/2018
| Address |
Industriepark Mechelen Noord
Mechelen BU 2800
Belgium
|
|
Employees
|
- |
| Website |
http://www.glpg.com |
| Updated |
07/08/2019 |
| Galapagos NV is a biotechnology company, which engages in the identification and development of small molecule and antibody therapies. It operates through the Research and Development and Fee-for-Services segment. The company was founded by Onno van de Stolpe, Rudi Pauwels, and Helmuth van Es on June 30, 1999 and is headquartered in Mechelen, Belgium. |
